Fingerprint
Dive into the research topics of 'Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis
James D. Chalmers (Lead / Corresponding author), Mark L. Metersky, Joseph Feliciano, Carlos Fernandez, Ariel Teper, Andrea Maes, Mariam Hassan, Anjan Chatterjee
Research output: Contribution to journal › Article › peer-review
7
Citations
(Scopus)
95
Downloads
(Pure)